Hanna Romanska-Knight

assistant professor

Medical University of Lodz

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Cancer Biology Cancer Biology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hanna Romanska-Knight is an assistant professor at the Medical University of Lodz in Poland. Her research focuses on breast cancer, including the molecular mechanisms underlying tumor progression, diagnostic challenges in rare tumors, and the role of various growth factor receptors in cancer therapy resistance. Recent publications highlight her expertise in areas such as FGFR signaling, tumor microenvironment analysis, and the prognostic implications of specific cancer subtypes.

Articles (12)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Rafal Sadej

Medical University of Gdansk

POLAND

View details

Adrianna Cieślak

Medical University of Lodz

POLAND

View details

Dominika Piasecka

Medical University of Gdansk

POLAND

View details

Marcin Braun

Medical University of Lodz

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hanna Romanska-Knight

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Microglandular adenosis associated with triple-negative invasive breast carcinoma – a case report and literature review

FGFR4-driven plasticity in breast cancer progression and resistance to therapy

Diagnostic challenge in chondromyxoid fibroma clinically mimicking neuroma

FGFR2‑triggered autophagy and activation of Nrf‑2 reduce breast cancer cell response to anti‑ER drugs

FGFR‑related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review)

Prognostic value of FGFR2 in ER-positive breast cancer is influenced by the profile of stromal gene expression: an in silico analysis based on TCGA data

Liver metastasis or a pseudocyst? A rare presentation of leiomyosarcoma’s metastasis in the liver

Subtype-Specific Tumour Immune Microenvironment in Risk of Recurrence of Ductal Carcinoma In Situ: Prognostic Value of HER2

FGF7/FGFR2–JunB signalling counteracts the effect of progesterone in luminal breast cancer

Hormonal Receptor Status Determines Prognostic Significance of FGFR2 in Invasive Breast Carcinoma

Adenoid cystic carcinoma of the breast – an uncommon malignancy with unpredictable clinical behaviour. A case series of three patients

The diagnostic challenge in pulmonary tumour embolism in cancer: a case report and literature review

Collaborators (4)

Rafal Sadej

Adrianna Cieślak

Dominika Piasecka

Marcin Braun

Make your next move.